Published Ahead-of-Print - Last Updated: September 10, 2018

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only


Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic

Apostolatos, André H.; Apostolatos, Christopher A.; Ratnayake, Wishrawana S.; More

Anti-Cancer Drugs. ., Post Author Corrections: September 10, 2018

Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells

Momeny, Majid; Eyvani, Haniyeh; Barghi, Farinaz; More

Anti-Cancer Drugs. ., Post Author Corrections: August 09, 2018

Apatinib reverses alectinib resistance by targeting vascular endothelial growth factor receptor 2 and attenuating the oncogenic signaling pathway in echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene-positive lung cancer cell lines

Chen, Yanqiong; Ma, Guoliang; Su, Cuiyun; More

Anti-Cancer Drugs. ., Post Author Corrections: August 02, 2018

Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models

Capasso, Anna; Pitts, Todd M.; Klauck, Peter J.; More

Anti-Cancer Drugs. ., Post Author Corrections: July 25, 2018

The anticancer effects of pharmacological inhibition of autophagy in acute erythroid leukemia cells

Kazemi, Alireza; Sadri, Mohammadreza; Houshmand, Mohammad; More

Anti-Cancer Drugs. ., Post Author Corrections: July 09, 2018


PDF Only



PDF Only


Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases

Lombardi, Giuseppe; Caccese, Mario; Bellu, Luisa; More

Anti-Cancer Drugs. ., Post Author Corrections: August 03, 2018

Pseudoprogression with subsequent complete response and severe thrombocytopenia to checkpoint inhibitor immunotherapy in a patient with advanced mucosal melanoma of the sinonasal cavity

Philipp, Magdalena; Frischhut, Nina; Tschachler, Antonia; More

Anti-Cancer Drugs. ., Post Author Corrections: June 26, 2018

A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor

Mollica, Veronica; Di Nunno, Vincenzo; Corcioni, Beniamino; More

Anti-Cancer Drugs. ., Post Author Corrections: June 18, 2018


PDF Only


Extravasation accidents with liposomal/liposomal pegylated anthracyclines treated with dexrazoxane: an overview and outcomes

Caballero Romero, Álvaro; Delgado Ureña, María Teresa; Salmerón García, Antonio; More

Anti-Cancer Drugs. ., Post Author Corrections: July 20, 2018

Show: